Pricing Log in Create free account

BioNexus Gene Lab Corp. (BGLC) vs J-Star Holding Co., Ltd (YMAT)

BioNexus Gene Lab Corp. and J-Star Holding Co., Ltd are both Specialty Chemicals companies. J-Star Holding Co., Ltd is the larger, with a market value of $6.1M against $3.6M — 1.7× the size. Across the 5 metrics below, J-Star Holding Co., Ltd leads on 3 and BioNexus Gene Lab Corp. on 2.

Valuation

Metric BGLC YMAT Specialty Chemicals median
P/E n/m — 25.37
P/S 0.93 — 1.46
P/B 0.37 n/m 1.84
Price to free cash flow n/m — 21.16
EV/EBITDA 0.25 n/m 12.82
EV/Sales (0.18) n/m 1.85
Earnings yield (105.00%) — 2.11%
Free cash flow yield (29.43%) — 2.16%

Profitability

Metric BGLC YMAT Specialty Chemicals median
Gross margin 12.34% — 29.23%
Operating margin (79.62%) — 3.63%
Net margin (82.36%) — 2.89%
Free cash flow margin (27.30%) — 3.76%
Return on equity (33.66%) — 3.62%
Return on assets (28.38%) — 0.35%
Return on invested capital (37.16%) 0.00% 2.75%

Growth

Metric BGLC YMAT Specialty Chemicals median
Revenue growth (TTM) (67.27%) — 4.51%
EPS growth (last fiscal year) (79.49%) (1,857.14%) (14.40%)
Revenue growth, 5-year CAGR (8.20%) — 6.30%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BGLC YMAT Specialty Chemicals median
Debt to equity 0.01 (1.87) 0.54
Current ratio 6.08 0.43 1.94
Net debt to EBITDA 1.49 (0.59) 2.03

Dividend

Metric BGLC YMAT Specialty Chemicals median
Dividend yield — — 1.73%
Payout ratio — — 0.41

Size

Metric BGLC YMAT Specialty Chemicals median
Market cap 3.59m 6.06m 2.41b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack